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ABSTRACT
Dengue fever is a mosquito-borne tropical disease caused by dengue virus. When 
infected by any of the four serotypes of dengue viruses, individuals may be 
asymptomatic or develop a dengue fever. The latter group can progress into severe form 
of dengue and the etiology of this is still uncertain. This study aims to elucidate copy 
number variations (CNVs) of the host genes as the factor causing dengue pathogenesis. 
Blood samples were collected from hospitalized dengue patients and proceeded to DNA 
extraction. DNA samples (136) were used for genotyping with Human Genome 
GeneChip 6.0. CNVs were called using Genotyping Console (GTC) 4.1 and Nexus Copy 
Number 7.0. Results from both algorithms were merged and stringent CNVs were 
filtered with three public databases; DGV, HapMap3 and SGVP in search for rare case- 
specific CNVs. Case-specific underlying genes were used in functional analysis with 
DAVID and IPA to explicate the dengue related biological processes. Significant genes 
of interest from both softwares were validated using qPCR. Hundred and thirty-six DNA 
samples from hospitalized dengue patients in four different hospitals were genotyped. A 
total number of 50,864 (24,806 gains and 26,059 loss) and 34,257 (31,725 gains and 
2,534 loss) CNV events were discovered by GTC and Nexus, respectively. After 
merging, only 3,052 (2,132 gain and 920 loss) stringent CNVs were left. After filtering 
with public known databases, of the 385 novel rare CNVs, 257 were specific for cases, 
and 128 were specific for controls, respectively (p = 0.388). Six hundred and eighty 
genes were found underlying the CNVs specific for cases and were eventually loaded 
into functional analysis softwares. GO terms from unbiased DAVID analysis such as 
defense response (p<0.001; Benjamini corrected p = 0.034), inflammatory response 
(p<0.001; Benjamini corrected p = 0.04) and response to cytokine stimulus (p<0.001; 
Benjamini corrected p = 0.038). From the biased IPA analysis, the candidate genes were 
clustered into enrichment with antigen presentation pathway as the most significant (p 
<0.001), followed by IL-12 signaling and production in macrophages (p <0.001), and 
interferon signaling (p <0.001). Genes from both significant GO terms and pathways; 
namely BCKDHB, CTSB, MR1, TAP2, TNFRS1B and CXCR4 were considered for 
validation using qPCR. The 9 out of 10 similarities between SNP 6.0 genotyping and 
qPCR supported the reliability of this assay. In conclusion, the rare CNVs may be 
involved in dengue pathogenesis. The rare CNV, which has been reported in other 
diseases (neuropsychiatric diseases, congenital heart disease and dilated 
cardiomyopathy), is reported for the first time in infectious diseases.
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CHAPTER ONE 
INTRODUCTION
1.1 BACKGROUND OF THE STUDY
Dengue, the most prevalent mosquito-borne viral disease-affecting people in 
the tropics and sub-tropic regions of the world, is caused by the infection of dengue 
virus (DENV). The virus exists as four (DENV 1-4) related but antigennically distinct 
serotypes. All four DENV serotypes have been co-circulated in Malaysia (Abubakar 
& Shafee, 2002; S. S. Wong, Abd-Jamil, & Abubakar, 2007). In majority of cases, 
infection by any of these DENV is asymptomatic, but it may also cause dengue fever 
(DF), a weakening flu-like illness that can lasts for up to two weeks (World Health 
Organization [WHO], 2009). Some of the cases, however, result in severe dengue that 
comprises of dengue shock syndrome (DSS), a life threatening manifestation.
Currently, no licensed vaccine or antiviral therapy exists for dengue infection. 
In Malaysia, year 2014 depicted the highest number of reported dengue cases and 
death. In fact, it was the highest throughout the history of dengue endemic in 
Malaysia where a 160% increment of dengue cases was seen from 2013 to 2014. 
However, the total number of cases may be underreported as the country uses passive 
surveillance system in capturing the incidence of dengue infection. In addition, there 
is a reason to be more vigilance as a very high IgG seropositivity (91.6%) was found 
in 1,000 healthy adults (Muhammad Azami, Salleh, Neoh, Syed Zakaria, & Jamal,
2011). This means, dengue can still be endemic for many more years in Malaysia.
Globally, WHO stated that DF and severe dengue cases have risen from less 
than a thousand cases in 1955 to almost 100,000 cases in 2007 annually. During that 
53 years, the number of countries reporting dengue cases also increased from just a 
few to more than sixty countries (WHO, 2009). In addition, dengue infection imposed 
significant health, economic and social burden on the population experiencing 
endemic outbreak. Intensive care is required for severely ill patients, including 
intravenous fluids, blood or plasma transfusion and medicines. On the economical
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